Myasthenia gravis during pregnancy

Simone Ferrero, Francesca Esposito, Mariangela Biamonti, Giorgio Bentivoglio, Nicola Ragni

Research output: Contribution to journalArticlepeer-review

Abstract

Myasthenia gravis (MG) affects women in the second and third decades of life, overlapping with the childbearing years. During pregnancy, the course of this disease is unpredictable; worsening of symptoms occurs more likely during the first half of pregnancy and postpartum. MG can be well managed during pregnancy with relatively safe and effective therapies. Cesarean section is recommended only for obstetric reasons; epidural anesthesia is advised to reduce physical and emotional stress. Anticholinesterase drugs are the mainstay of treatment, when MG symptoms are not satisfactorily controlled, corticosteroids, azathioprine and in some cases cyclosporin A may be used. Life-threatening conditions (e.g., respiratory insufficiency) may occur during pregnancy; therefore, intensive check-ups by a gynecologist and a neurologist are necessary.

Original languageEnglish
Pages (from-to)979-988
Number of pages10
JournalExpert Review of Neurotherapeutics
Volume8
Issue number6
DOIs
Publication statusPublished - Jun 2008

Keywords

  • Delivery
  • Diagnosis
  • Myasthenia gravis
  • Pregnancy
  • Treatment

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Myasthenia gravis during pregnancy'. Together they form a unique fingerprint.

Cite this